Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
| ▸ | TGM2 | P21980 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21777817 | 1.00 | TSHR (0.41) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL27741 | 0.98 | TSHR (0.42) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL23888730 | 0.98 | TSHR (0.42) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| Ammonia Solution, Strong SCHEMBL22116161 | 0.97 | TSHR (0.41) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL8599088 | 0.97 | TSHR (0.41) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL23148185 | 0.97 | TSHR (0.41) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| Acrylic Acid SCHEMBL15387828 | 0.93 | TSHR (0.38) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| Vinylsulfonic Acid SCHEMBL8505834 | 0.93 | TSHR (0.38) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| Acrylamide SCHEMBL27834778 | 0.92 | TSHR (0.37) | TSHRALDH1A1MAPK1TDP1ZDHHC20 | |
| SCHEMBL22411220 | 0.86 | TSHR (0.43) | TSHRALDH1A1MAPK1TDP1ZDHHC20 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240247182-A1 | FRACTURING METHODS USING TAGGED POLYMERS | KEMIRA OYJ (FI) | 2024-07-25 | — | — | US | claimed |
| WO-2022256429-A1 | FRACTURING METHODS USING TAGGED POLYMERS | KEMIRA OYJ (FI) | 2022-12-08 | — | — | WO | claimed |
| EP-2059272-B1 | COATING FORMULATION FOR MEDICAL COATING | DSM IP ASSETS BV (NL) | 2018-02-28 | — | — | EP | claimed |
| US-20100076546-A1 | COATING FORMULATION FOR MEDICAL COATING | DSM IP ASSETS B.V. (NL) | 2010-03-25 | — | — | US | claimed |
| US-20240247182-A1 | FRACTURING METHODS USING TAGGED POLYMERS | KEMIRA OYJ (FI) | 2024-07-25 | — | — | US | disclosed |
| CN-114846078-B | Inverse latex for cosmetic compositions combining tetrasodium salt of glutamic acid N, N-diacetic acid as chelating agent and polyelectrolyte comprising AMPS and acrylamide | 化工产品开发公司SEPPIC | 2024-03-29 | — | — | CN | disclosed |
| US-20240059892-A1 | FUNCTIONALIZED POLYACRYLATE POLYMER COMPOSITIONS | HUNTSMAN INT LLC (US) | 2024-02-22 | — | — | US | disclosed |
| US-11827784-B2 | Functionalized polyacrylate polymer compositions | HUNTSMAN INTERNATIONAL LLC (US) | 2023-11-28 | — | — | US | disclosed |
| WO-2023122465-A2 | COSMETIC COMPOSITION COMPRISING MICA AND LAUROYL LYSINE | THE PROCTER & GAMBLE COMPANY (US) | 2023-06-29 | — | — | WO | disclosed |
| CN-115073754-B | Functionalized polyacrylic polymer composition | 亨茨曼国际有限公司 | 2023-06-27 | — | — | CN | disclosed |
| WO-2022256429-A1 | FRACTURING METHODS USING TAGGED POLYMERS | KEMIRA OYJ (FI) | 2022-12-08 | — | — | WO | disclosed |
| CN-115073754-A | Functionalized polyacrylic polymer compositions | 亨茨曼国际有限公司 | 2022-09-20 | — | — | CN | disclosed |
| US-20080253986-A1 | Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2008-10-16 | — | — | US | disclosed |
| EP-1933827-A2 | COMPOSITION COMPRISING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE COMPOUND OF POLYURETHANE POLYMER TYPE OR DERIVATIVES THEREOF, PREPARATION PROCESSES THEREFOR AND USES THEREOF | Galderma Research & Development, S.N.C. (FR) | 2008-06-25 | — | — | EP | disclosed |
| WO-2008031595-A2 | COATED MEDICAL DEVICE | DSM IP ASSETS B.V. (NL) | 2008-03-20 | — | — | WO | disclosed |
| WO-2008031596-A1 | COATING FORMULATION FOR MEDICAL COATING | DSM IP ASSETS B.V. (NL) | 2008-03-20 | — | — | WO | disclosed |
| WO-2007031883-A2 | COMPOSITION COMPRISING AT LEAST ONE NAPHTHOIC ACID DERIVATIVE AND AT LEAST ONE COMPOUND OF POLYURETHANE POLYMER TYPE OR DERIVATIVES THEREOF, PREPARATION PROCESSES THEREFOR AND USES THEREOF | GALDERMA RESEARCH & DEVELOPMENT (FR) | 2007-03-22 | — | — | WO | disclosed |
| CN-1082570-C | Ionically conductive agent, system for cathodic protection of galvanically active metals, and method and apparatus for using same | MINNESOTA MINING & MFG (US) | 2002-04-10 | — | — | CN | disclosed |
| EP-0950539-B1 | Thermal dye transfer receiving element | EASTMAN KODAK CO (US) | 2001-06-13 | — | — | EP | disclosed |
| EP-0950539-A1 | Thermal dye transfer receiving element | EASTMAN KODAK COMPANY (US) | 1999-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080253986-A1 | Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers | CUTA, NACA, PUF60 | TSHR 4056/4885ALDH1A1 677/4885MAPK1 2515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.